Clinical challenges of an Xp21 contiguous gene deletion syndrome in a newborn and 15 months of follow-up - case report - Summary - MDSpire

Management Difficulties in a Newborn with Xp21 Contiguous Gene Deletion Syndrome: A 15-Month Case Study

  • By

  • Ignacy Frulenko

  • Iwona Ostrowska

  • Michał Patalan

  • Aida Bertoli-Avella

  • Nayla Y. León

  • Andreia Pinto

  • Peter Bauer

  • Alicja Leśniak

  • Daria Katuszonek

  • Marta Glińska

  • Monika Modrzejewska

  • Robert Śmigiel

  • Maria Giżewska

  • July 20, 2026

Share

Objective:

To report a case of a male child with Xp21 contiguous gene deletion syndrome and illustrate the diagnostic challenges and clinical complexities associated with this condition.

Approach:
  • Method: A
  • Method: f
  • Method: u
  • Method: l
  • Method: t
  • Method: e
  • Method: r
  • Method: m
  • Method: C
  • Method: s
  • Method: i
  • Method: n
  • Method: w
  • Method: b
  • Method: o
  • Method: d
  • Method: 8
  • Method: y
  • Method: p
  • Method: ,
  • Method: g
  • Method: h
  • Method: j
  • Method: v
  • Method: k
  • Method: 4
  • Method: 5
  • Method: z
  • Method: X
  • Method: 2
  • Method: 1
  • Method: 3
  • Method: 0
  • Method: 6
  • Method: 7
  • Method: 9
Key Findings:
  • The patient developed salt-wasting primary adrenal insufficiency with hyponatremia and hyperkalemia.
  • Significant glyceroluria and severe serum hypertriglyceridemia were noted, consistent with glycerol kinase deficiency.
  • The child exhibited global developmental delay by 15 months, particularly in gross motor and language skills.
Interpretation:

The case highlights the importance of early molecular diagnosis in managing Xp21 contiguous gene deletion syndrome, which can facilitate timely interventions.

Limitations:
  • The study is based on a single case, which may limit the generalizability of the findings.
  • The impact of multi-gene deletions on clinical outcomes remains incompletely understood.
Conclusion:

Early diagnosis and management are crucial for addressing the complex clinical manifestations of Xp21 contiguous gene deletion syndrome.

Original Source(s)

Related Content